Genomic & Biopharma News

Immune Cell Bank Bets on Future CAR T Success
The company Cell Vault offers to hold consumers' T cells for later use, but scientists suggest the service would benefit very few users.
The Scientist, 2019-08-16 19:52:07

Special Schwann Cells in Mice Play Unsung Role in Pain
The glia seem to make up part of a newly described sensory organ, the discoverers suggest.
The Scientist, 2019-08-16 18:54:38

AbbVie scores blockbuster approval for RA med Rinvoq, its crucial Humira follow-up
The second of AbbVie’s highly anticipated 2019 blockbuster candidates is here. Friday, the FDA greenlighted Rinvoq, a rheumatoid arthritis med meant to succeed best-selling Humira as copycats bite into its sales. The new product should be available in the U.S. by late August, AbbVie said.
Fierce Pharma, 2019-08-16 18:02:32

Chemist Richard Van Duyne Dies
The Northwestern University professor developed surface-enhanced Raman spectroscopy, an invaluable technique for detecting and identifying individual molecules.
The Scientist, 2019-08-16 17:00:21

Key hires during Q2 2019 at ORB
Deerfield Beach, July 19, 2019 - Ocean Ridge Biosciences (ORB) announces two key hires in Q2 2019.
ORB Company News, 2019-07-20 00:49:36

FDA approves first spinal tether implant for correcting childhood scoliosis
The FDA approved the first spinal tether medical device to correct the most common form of scoliosis in children and adolescents—a ropelike implant that pulls the vertebrae into shape as the child grows.
Fierce Biotech, 2019-08-16 15:33:37

In a boon for buyer Bristol-Myers, Celgene's JAK med Inrebic scores FDA nod
Bristol-Myers Squibb’s $74 billion Celgene takeover has been a roller coaster, with some Revlimid patent wins on the upside and, on the down, an FTC-forced sale of blockbuster Otezla. But the FDA just handed the merger partners another win.
Fierce Pharma, 2019-08-16 15:30:09

Despite failed promises, stem cell advocates again want taxpayers to pony up billions
Californians voted in 2004 to shell out billions of dollars in taxpayer money to fund cutting-edge stem cell treatments.
News Medical Life Sciences, 2019-08-16 15:02:35

Investors angry about insulin woes sue Novo Nordisk in Denmark for $1.75B
A group of investors sued Novo Nordisk in Denmark for allegedly misleading the public about its insulin franchise's downward spiral. The lawsuit claims $1.75 billion in losses as pricing pressures and falling sales sent share prices downward—and as Novo points out, broadly resembles a shareholder suit filed in the U.S.
Fierce Pharma, 2019-08-16 14:54:08

ORB Employees Participate in 2019 Martin Luther King Day Event
ORB employees get a rare break from the lab on January 21, 2019. A group of Ocean Ridge Biosciences employees stepped out of the lab on a beautiful South Florida winter day to take part in an event honoring Martin Luther King. We got our hands dirty planting some flowers and shrubs at a local park in Deerfield Beach.
ORB Company News, 2019-01-22 23:24:59

Debt-laden Glenmark counts on assets sales, spinoffs to dig it out
Glenmark Pharmaceuticals’ makeover is painfully loaded with slow revenue growth and high capital spend simultaneously. In the hope of reducing debt, the Indian drugmaker now plans to sell some of its noncore assets after spinning off its API and innovative R&D businesses.
Fierce Pharma, 2019-08-16 14:50:53